KIR2DL5B
gene geneOn this page
Also known as KIR2DL5.2KIR2DL5KIR2DL5.3KIR2DL5.4
Summary
KIR2DL5B (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5B, HGNC:16346) is a protein-coding gene on chromosome 19q13.4 alternate reference locus, encoding Killer cell immunoglobulin-like receptor 2DL5B (Q8NHK3). Receptor on natural killer (NK) cells for HLA-C alleles.
Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several “framework” genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.
Source: NCBI Gene 553128 — RefSeq curated summary.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16346 |
| Approved symbol | KIR2DL5B |
| Name | killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5B |
| Location | 19q13.4 alternate reference locus |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIR2DL5.2, KIR2DL5, KIR2DL5.3, KIR2DL5.4 |
| OMIM | 615727 |
| Entrez | 553128 |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 7)
- Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. (PMID:17215859)
- Promoter variants of KIR2DL5 add to diversity and may impact gene expression. (PMID:18461314)
- Alleles commonly found in a Northern Irish population of 354 individuals were KIR2DL5A*001, KIR2DL5A*005, and KIR2DL5B*002. (PMID:18498296)
- KIR2DL3, KIR2DS5 and KIR2DL5B genes may be correlated with pathogenesis of nasopharyngeal carcinoma in the Chinese southern Han population. (PMID:21729574)
- indicate that killer-cell immunoglobulin-like receptors (KIRs)activator (KIR3DS1 and KIR2DS5) and inhibitory (KIR2DL5) genes are associated with severe pandemic influenza A (H1N1) 2009 infections. (PMID:22652695)
- We found the presence of KIR2DL5B to be associated with inferior transformation-free survival and event-free survival in patients with chronic phase-chronic myeloid leukemia (PMID:26500342)
- KIR2DL5B and HLA DRB1*12 alleles seems to be associated with protection against HIV-1 in serodiscordant couples in Burkina Faso. (PMID:35501290)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Killer cell immunoglobulin-like receptor 2DL5B — Q8NHK3 (reviewed: Q8NHK3)
Alternative names: CD158 antigen-like family member F2, Killer cell immunoglobulin-like receptor 2DLX
All UniProt accessions (0):
UniProt curated annotations — full annotation on UniProt →
Function. Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis.
Subcellular location. Cell membrane.
Similarity. Belongs to the immunoglobulin superfamily.
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003599 | Ig_sub | Domain |
| IPR013151 | Immunoglobulin_dom | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR050412 | Ig-like_Receptors_ImmuneReg | Family |
Pfam: PF00047
UniProt features (18 total): sequence variant 3, compositionally biased region 2, disulfide bond 2, topological domain 2, domain 2, region of interest 2, signal peptide 1, chain 1, glycosylation site 1, sequence conflict 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NHK3-F1 | 72.12 | 0.40 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 49–95, 144–193
Glycosylation sites (1): 218
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 8 (showing top):
GOBP_REGULATION_OF_IMMUNE_RESPONSE, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY, GOBP_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION, GOMF_IMMUNE_RECEPTOR_ACTIVITY, GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY, GOBP_REGULATION_OF_IMMUNE_SYSTEM_PROCESS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (1): immune response-regulating signaling pathway (GO:0002764)
GO Molecular Function (0):
GO Cellular Component (1): plasma membrane (GO:0005886)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 1 |
| regulation of immune response | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0G2KBC9, A1YIY0, B6A8R8, C0HJX2, C0HJX3, D3ZQX2, P08101, P0C1X9, P0DTI4, P12314, P12318, P26151, P43626, P43627, P43628, P43629, P43630, P43631, P43632, P83555, P83556, P97484, Q01965, Q13291, Q14943, Q14952, Q14953, Q14954, Q28942, Q3B8P2, Q60513, Q61450, Q63203, Q64281, Q68SN8, Q6UX27, Q7TQA1, Q7Z6M3, Q8BG84, Q8BHK6
Diamond homologs: A0A0G2KBC9, A6NI73, C0HJX2, C0HJX3, D3ZQX2, O75019, O75022, O75023, O76036, P0C191, P24071, P43626, P43629, P43630, P59901, P83556, P97484, Q14943, Q14954, Q61450, Q64281, Q6GTX8, Q6ISS4, Q6PI73, Q7TQA1, Q863H2, Q8C567, Q8IYS5, Q8MJZ2, Q8MJZ7, Q8N109, Q8N149, Q8N423, Q8N6C8, Q8N743, Q8NHJ6, Q8NHK3, Q8NHL6, Q95JB9, Q9HCN6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1001413674 (19:54753670 G>A), RS1011377084 (19:54753914 A>G), RS1022363799 (19:54753915 T>C), RS1022860612 (19:54753383 C>G), RS1029872281 (19:54753972 T>C), RS1033599658 (19:54753739 T>C), RS1033674621 (19:54753229 T>C), RS10422679 (19:54753963 A>T), RS10423983 (19:54754310 G>A,C,T), RS111841886 (19:54753969 T>G), RS114861744 (19:54753612 C>A,T), RS1156871204 (19:54753434 G>T), RS1156883326 (19:54754430 G>A), RS1157399369 (19:54753217 A>G), RS1159106814 (19:54754270 C>T)
Disease associations
OMIM: gene MIM:615727 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Amiodarone | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.